Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning
Active, not recruiting
- Conditions
- Esophageal Neoplasm
- Interventions
- Radiation: Neo-Adjuvant RadiotherapyDrug: Neo-Adjuvant ChemotherapyProcedure: Esophagectomy
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2022-12-28
- Lead Sponsor
- Dr Kundan Singh Chufal
- Target Recruit Count
- 150
- Registration Number
- NCT04489368
- Locations
- 🇮🇳
Rajiv Gandhi Cancer Institute & Research Center, New Delhi, Delhi, India
🇦🇺Illawarra Cancer Care Centre, Wollongong, Australia
© Copyright 2025. All Rights Reserved by MedPath